Top 50 Health Care Startup Investors in Israel in October 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Health care startups based in Israel. We rank investors based on the number of investments they made in Health care companies from Israel. We update this investor list every month.Top 50 Health Care Startup Investors in Israel in October 2024
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Funding Round, Series A
- Israel, Singapore, United Kingdom
Portfolio highlights
- AgriG8 — AgriG8 is an enterprise designed to align, collaborate, de-risk and grow value chains and ecosystems within the agricultural industry.
- Peptobiotics — We make agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new new type of antibiotic alternative that does not cause resistance. Our recombinant peptides are synthetic biology products manufactured in a patent pending precision fermentation process. We are launching a range of products across livestock and aquaculture in Asia.
- ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
Access exclusive venture capital angel investment deals in pre-vetted startup companies. Create your free OurCrowd investor account today!
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series B, Series A, Seed
- Israel, United States, Canada
Portfolio highlights
- Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
- Jooules — Jooules offers a sustainable food system to ensure a greener, healthier future by using fermentation technologies to create nutritious protein ingredients.
- Metrovate — Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.
The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Grant, Seed, Pre-Seed
- Israel, United States, Mali
Portfolio highlights
- BloomX — Helping nature do its magic with the power of technology
- Pickommerce — Pickommerce specializes in robotic grasping and focused on logistic solutions, primarily with our autonomous Pick & Pack integrated system. We are on a mission to promote work productivity and facility efficiency in logistic warehouses while ensuring seamless operation.
- NurExone Biologic — NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series A, Series D
- Israel, United States
Portfolio highlights
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
- Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
- Click Therapeutics — Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive datascience platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- Chemomab — Pioneering Innovative Treatments for Patients with Fibrosis-Related Diseases
- MBX Biosciences — Homepage - MBX Biosciences
- Brenig Therapeutics — Brenig Therapeutics develops therapies for neurodegenerative disorders.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series B, Seed
- United States, Israel, Ireland
Portfolio highlights
- FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.
We partner early with global-minded entrepreneurs seeking to disrupt large markets
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Series B, Series A, Series C
- Israel, United States, Canada
Portfolio highlights
- Nagish — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
- Unity SCM — Data across your entire supply chain easily collected and organized in one place
- Seal Security — Streamline your open source vulnerability remediation without introducing the risk of breaking changes. Say goodbye to alert fatigue and start patching with Seal Security.
Firstime Ventures is investing in companies who are building a sustainable & accessible future for all.
Show more
Investment focus
- Software, Machine Learning, Artificial Intelligence
- Seed, Series A, Series B
- Israel, United States, United Kingdom
Portfolio highlights
- Baibys — Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF.
- Pixellot — Pixellot is a leading sport media company that offers automatic production solutions for the amateur and semi-professional market. Pixellot’s patented technology streamlines the production workflow by deploying an unmanned multi-camera system that covers the entire field. Advanced algorithms enable dynamic coverage of the flow of play and highlightgeneration. The company streams more than 11,000 live video hours each month to fans, players, and coaches on a variety of platforms. Founded in 2013 by seasoned video and media technology experts, Pixellot has sold over 2,000 systems around the world, deployed with minor leagues, high schools, as well as at youth academies and top league clubs. Pixellot’s partners include ESPN, PlayOn Sports, the US’ biggest high school sports media company and right holder, Sporttotal.tv, Germany’s largest amateur league media platform, global coaching solution provider STATS, SeeUPlay in Mexico and Hockey TV, North America’s largest non-NHL ice hockey streaming platform. The company also works directly with leading clubs such as Bayern Munich, Spain’s Real Sociedad, Dutch AZ Alkmaar and Maccabi Tel-Aviv.
- Securithings — Bringing IT Standards to the IoT Space.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series A, Series B, Series C
- Israel, United States, China
Portfolio highlights
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
- Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Funding Round, Series C, Series A
- Israel, United States
Portfolio highlights
- Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
aMoon is a leading healthtech & life sciences venture capital firm.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Israel, Switzerland
Portfolio highlights
- AltruBio — AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.AltruBio International in Delaware with principal office in SFO Bay Area California is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment ofcancer and immune-related inflammatory diseases.With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for unmet medical needs.Their R&D scientists built an efficient discovery platform to identify and validate novel antibody therapeutics.Currently, AbGenomics has several potential therapeutic antibodies targeting autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors in various development stages.
- Eleos Health — Automate documentation, alleviate provider burnout, and elevate care quality with the CareOps Automation platform from Eleos Health.
- Ibex Medical Analytics — Ibex Medical Analytics develops AI-driven clinical decision support tools that help pathologists deliver more efficient, metric-driven, objective and accurate diagnosis. It combines AI, data science, image analysis and machine learning technologies and applies them to cancer diagnostics in digital pathology.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more
Investment focus
- Information Technology, Health Care, Software
- Seed, Series A, Funding Round
- Israel, United States, China
Portfolio highlights
- Creednz — Creednz is a company that provides financial data management system that involves internal financial data sets.
- Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
- Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Series B
- Israel
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more
Investment focus
- Health Care, Medical Device, AgTech
- Funding Round, Seed, Series A
- Israel
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- FruitSpec — FruitSpec provides customers with the ability to manage their yield, using accurate yield estimation solution.
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
SeedIL Ventures is a seed stage investment fund focusing on Israeli related companies in any sector except medtech/biotech and heavy Hardware.
After investment, SeedIL is committed to ensuring that portfolio companies reach their full potential by providing on-going coaching and connections through its extensive network, including the Limitedpartner's connections and intelligence.
Show more
Investment focus
- Artificial Intelligence, Software, Big Data
- Seed, Series A, Pre-Seed
- Israel, United Kingdom, Australia
Portfolio highlights
- Wisor — Propelling the supply chain industry into the digital age Wisor is a plug & play solution that provides a global automated quoting solution that allows freight forwarders to generate quotes and communicate with clients automatically Get a demo What took days now takes minutes Wisor is specifically designed to support and simplify the complexity of generating quotes
- BlinqIO — BlinqIO developed an autonomous AI-operated virtual tester (BVT) - the BVT receives as input test scenarios, takes decisions how to perform the tests and creates in the background test automation code.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio.
It's never too early to have a conversation about your startup.
Show more
Investment focus
- Health Care, FinTech, Education
- Seed, Pre-Seed, Series A
- Israel, United States, Norway
Portfolio highlights
- enso — enso offers AI-powered bot bundles to automate your marketing strategy. Perfect for small business owners, our bots handle social media, SEO, lead generation & much more. Start with a 7 days free trial or talk with one of our marketing experts today.
- Carbon Blue — Carbon Blue is developing an 'ocean-capture' scalable method for removing CO2 from the atmosphere. The company was founded by Iddo Tsur and Dan Deviri.
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Seed, Series A, Funding Round
- Israel
Portfolio highlights
- QTflow Ltd. — A Micro Air Pump Technology: The Future of Thermal Management
- CVAid Medical — CVAid Medical develops an innovative AI based stroke detection technological platform.
- TailorMed — Moving Mountains for Patients
Healthcare innovation wherever it originates.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Israel, United Kingdom
Portfolio highlights
- Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Early Stage VC
Show more
Investment focus
- Software, Biotechnology, Machine Learning
- Seed, Pre-Seed, Series A
- Israel, United States, United Kingdom
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
- Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies.
Our golden eggs
Ayana Pharma
A late stage company with
Show more
Investment focus
- Biotechnology, Pharmaceutical, Life Science
- Seed, Series B, Series F
- Israel
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
TAU Ventures is an early-stage focused venture capital fund affiliated with Tel Aviv University, investing in the next generation of impactful home-grown technology companies. At the heart of the start-up nation, TAU Ventures invests the first capital into startups and is dedicated to helping them transform their ideas into global businesses.TAU Ventures cultivates an innovation ecosystem by combining the resources and global network of Tel Aviv University, strong industry connections, and a supportive home-base for founders. Together with its world-leading team of experienced mentors, TAU Ventures empowers startups in their critical, early steps. At its 1000 sq meter co-working office space located in Tel Aviv, the team works shoulder to shoulder with their portfolio companies, nurturing their growth by drawing on the strength of its innovation ecosystem on a daily basis.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Pre-Seed, Series A
- Israel, United States
Portfolio highlights
- TaTiO — TaTIO is delivering a smarter way to hire through competency-based sourcing that combines artificial intelligence and job experience simulations to guarantee qualified candidates.
- Cerby — Collaborate without chaos. Cerby helps your team be productive while protecting your brand. Secure unmanageable applications. Only with Cerby.
- Liquid360 — A 3D, one-glance visual of your site with x-ray vision for rapid risk assessment. See through walls and around corners for maximum intel.
J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more.
Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.
Show more
Investment focus
- Software, Health Care, Machine Learning
- Series A, Seed, Pre-Seed
- United States, Israel
Portfolio highlights
- Allstar — Allstar is a gaming company that believes every gamer can become a content creator, with the right tools. The company is driven by its mission is to make the everyday gamer the star of their greatest esports moments through technology that enables them to effortlessly create, discover, and share their own professional quality esports highlights.
- Bria — Bria is a Computer Software company.
- Cents — Cents is the #1 point of sale and business management platform for laundromats to grow, manage and understand their business. Schedule a free demo.
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Funding Round
- Israel, United States, Switzerland
Portfolio highlights
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- Honeycomb — Honeycomb (fka Agilius) is the only place where you can buy a condo/apartment building master policy online in less than 3 minutes at a fraction of the cost! Instant, free, no hassle quotes, online everything and up to 40% savings. With all that we're bringing simplicity and transparency to the real estate insurance space for condoassociations (HOAs), building owners, property managers, and developers everywhere. This is what we do. This is all we do.
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
We're a team of former serial founders managing over $1.25B across a number of funds, with offices in Tel Aviv, London, and New York.
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Series A, Series B
- Israel, United States, United Kingdom
Portfolio highlights
- PointFive — PointFive provides ongoing cloud cost savings by providing deeper detection and collaborative repair solutions that fit smoothly into teams' normal operations.
- MagnusMetal — Magnus_Metal - Digital Era has arrived for Metal Casting. MagnusMetal team is taking casting, a 6000 years old technology, to the digital Industry 4.0 era, with our breakthrough patent pending, volume alloy Digital Casting System and process
- Sensi.Ai — Sensi.Ai developed the first audio AI that's able to analyze the routine in long term care environments, detect anomalies and provide insight on trends, with the purpose of improving the quality of care
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point.
Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Health Care
- Series A, Funding Round, Seed
- Israel, United States, Germany
Portfolio highlights
- CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
- Wisdo Health — Our award-winning social health platform utilizes SDOH assessments and pro-social measures to increase quality of life and decrease medical spending.
- WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.
Show more
Investment focus
- Health Care, Software, Artificial Intelligence
- Seed, Series A, Series B
- United States, Israel, India
Portfolio highlights
- PatientPartner — Supporting the community one surgery at a time
- Heyday Health — Discover virtual and in-home primary care for seniors on Medicare Advantage. Same day appointments available
- Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Seed, Series A, Series B
- Israel, United States, Cyprus
Portfolio highlights
- BlinqIO — BlinqIO developed an autonomous AI-operated virtual tester (BVT) - the BVT receives as input test scenarios, takes decisions how to perform the tests and creates in the background test automation code.
- Fairgen — Data-centric approach to debiasing machine learning models and artificial intelligence algorithms.
- With (Coing) — An holistic solution focusing on those who put their people first. Save time, make data-based decisions, boost engagement.
The Chartered Group is an investment platform.
Show more
Investment focus
- Biopharma, Agriculture, Health Care
- Funding Round, Series A, Private Equity
- Israel
Portfolio highlights
- Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
- Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more
Investment focus
- Health Care, Wellness, Food and Beverage
- Series A, Seed, Series B
- United States, United Kingdom, India
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Append Medical — A novel transcatheter LAA elimination system
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.
Show more
Investment focus
- Software, Machine Learning, Health Care
- Seed, Series A, Funding Round
- Israel, United States
Portfolio highlights
- Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
- Cybord — Electronics components' quality, reliability, and highest level of traceability by leveraging visual AI and BigData
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Funding Round
- United States, Israel, Canada
Portfolio highlights
- AmpUp — Commercial electric vehicle (EV) charging network solutions made simple for everyone. Easily manage and analyze EV charging data from a single dashboard.
- Oxylus Energy — Oxylus Energy provides new carbon utilization technology for the generation of e-fuels It strives to make CO2 capture and conversion competitive, scalable, and circular for a decarbonized future.
- Halda Therapeutics — Halda Therapeutics is a research-stage drug discovery company, seeking to create the next generation of precision medicine based on a novel therapeutic modality which may be a platform for a number of disease states.
Hanaco Ventures backs early-stage technology companies with visionary and passionate entrepreneurs. Hanaco was founded by Alon Lifshitz, Lior Prosor, and Pasha Romanovski in 2017 and is headquartered in Tel Aviv, Israel.
Show more
Investment focus
- Software, Financial Services, Cyber Security
- Series A, Seed, Series C
- United States, Israel, United Kingdom
Portfolio highlights
- Firefly — Firefly provides the cloud infrastructure management tools missing from traditional CMDBs
- Route — Track Everything You Order in the Route App. Get shipping notifications and real-time status updates on any delivery.
- ZEST Security — ZEST is the AI-powered risk resolution platform that's redefining cloud risk remediation for security and DevOps teams.
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Seed, Series A, Pre-Seed
- Germany, Israel, United States
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- FieldIn — Fieldin delivers risk mitigation for high value crops, helping farmers stay competitive against shrinking prices and profits.
- Arugga AI Farming — Arugga develops ground robots to treat and monitor individual plants in the greenhouse. We are proud to be the first company to commercialize a robot that successfully replicates (bumblebee) buzz pollination in tomato greenhouses.
- Intuition Robotics — The AI care companion robot for older adults
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Software
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
- Ramon.Space — Ramon.Space builds space-resilient super-computer systems that bring cloud computing to space. The New Space market is driven by privatization and commercial goals that give birth to new space services and applications. The demand for significant processing power, storage and better intelligence creates a huge market potential. Yet, the scale ofcomputing capabilities required for New Space applications is not available today due to environmental challenges such as radiation and extreme temperatures. Powered by its unique AI/ML processors, Ramon.space’s software-defined systems enable the realizations of earth-like computing capabilities in space. The company's proven technology is already deployed in space, and is used in many satellites and in more than 50 space missions across the solar system - with zero failures. With its innovative technology and an enthusiastic team that constantly pushes the boundaries of technology, Ramon.Space is set to lead the digital transformation of space.
- Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley.
Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal.
Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences.
Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Series B
- United States, Israel, India
Portfolio highlights
- UpdateAI — The leading AI notetaker and voice-of-the-customer intelligence platform for every customer-facing SaaS team.
- HATCH — HATCH is the first of its kind Giving Intelligence Platform. An AI-powered portal for Fundraisers, Marketers and Volunteers to streamline and Maximize their impact. A new home for a new world of giving!
- OrdinalsBot — We make it easy to inscribe ordinals. Like, really easy.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more
Investment focus
- Software, Artificial Intelligence, Aerospace
- Seed, Funding Round, Series A
- Israel, United Kingdom, Estonia
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.
Show more
Investment focus
- Wellness, Biotechnology, Manufacturing
- Series A
- Israel
Portfolio highlights
- SolCold — We make the sun cool again - Solcold the new environment solutions
- Trobix Bio — Trobix Bio is a company that develops and commercializes antibacterial products. It has developed platform technologies called ActiSense and GOTrap for developing high-quality products that remove the threat of antimicrobial resistance.
Established in 1997 as the venture arm of XT Holdings, XT Hi-Tech is one of the early investors in Israeli startups. Since inception, we have invested in over 80 companies in various technology categories and at different stages, including Phytech, Checkmarx, Enzymotec, Cymbio, Sofwave, and Lumenis.
Show more
Investment focus
- Health Care, Medical Device, Agriculture
- Seed, Series A, Funding Round
- Israel
Portfolio highlights
- Cymbio — Connect to hundreds of digital sales channels via Cymbio's automated multi channel e-commerce platform to increase sales & elevate revenue.
- BlueThrone — BlueThrone is a Technology-Driven App Appreciation Company that Buys and Grows Great iOS Apps
- NeuReality — NeuReality is the first complete, system-level solution designed to address the challenges of optimizing, deploying, managing, and scaling AI workflows.
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
Show more
Investment focus
- Pharmaceutical, Cannabis, Biopharma
- Funding Round, Corporate Round
- Israel
Portfolio highlights
- LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
- MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more
Investment focus
- Software, Cyber Security, Transportation
- Seed, Series B, Series A
- Israel, United States
Portfolio highlights
- Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more
Investment focus
- Biotechnology, Life Science, Biopharma
- Seed, Funding Round
- Israel
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
Aster is a Venture Capital firm with offices in 4 major innovation hubs: Paris, London, Tel Aviv and San Francisco. Since 2000, they have partnered with more than 60 teams of entrepreneurs that are transforming markets with disruptive offers and technologies. They are always open to exploring new ideas related to mobility, energy and industrysectors that they have been covering until now. They invest in all stages, with a preference for the early phase.They are more than investors and they intend to act as an ally for entrepreneurs by connecting them to a valuable ecosystem of experts, influencers and business leaders. From marketing to executive talent, their commitment to the growth of their portfolio companies as well as the entire venture ecosystem also involves the commitment of their dedicated Operations team, their innovation strategy consulting firm (Aster Fab) and a crowdfunding branch to further expand opportunities (Aster Crowd).Some of their success stories include Solairedirect (acquired by Engie in 2015), Digital Lumens (acquired by Osram in 2017) and Avantium (IPOed in 2017).
Show more
Investment focus
- Software, Energy, Manufacturing
- Series A, Funding Round, Series B
- France, United States, United Kingdom
Portfolio highlights
- EyeLights — EyeLights is a Head Up Display GPS. It allows motobikers to truly experience the ride by keeping their eyes on the road. Eyelights is the first universal motorcycle accessory that projects guidance, danger zones and traffic directly into your field of vision. A dangerous bend, a nearby stopper or speed over limitations, EyeLights warns you. Simple,uncluttered, they adapted the display for motorcycle riding.The EyeLights product installs in less than 5 minutes on your full-face, convertible or jet helmet. Their compact optical technology allows you to view your GPS more than 2 meters away while enjoying audio functions for more than 8 hours. The product is compatible with sun visors, insensitive to rain or fog and weighs less than 100g.
- Neural Concept — Neural Concept is the first AI software for enhanced engineering. Leverage your historical CAD and CAE data to drastically shorten and improve your design cycles.
- LevelTen Energy — LevelTen Energy provides transaction infrastructure for buyers, sellers, advisors, and financiers in the renewable energy economy.
Early-stage venture firm investing in exceptional entrepreneurs who seek to build category-defining companies.
Show more
Investment focus
- Software, Gaming, Mobile
- Seed, Pre-Seed, Series A
- Israel, United States, The Netherlands
Portfolio highlights
- Kryptomon — Kryptomon is an NFT Play-and-Earn blockchain game, where Pokémon meets Tamagotchi and CryptoKitties. Breed, Train and Fight with your NFT Kryptomon. It's a new world where trainers can live a new adventure on Blockchain. Set in the Kryptomon metaverse, community members play as ‘Trainers’ of their own individual monsters — Kryptomons — each ofwhich is a completely unique digital asset connected to an NFT. Each has a unique but mutable genetic code made up of 38 randomised parameters that determine all of the aspects — physical and behavioral — of the creature. This not only ensures that each Kryptomon is unique but also brings to life each Kryptomon as a digital companion in the Kryptomon metaverse. They are capable of learning, falling sick, getting hungry, and protecting their trainers when out on an adventure in the physical world. In turn, trainers will have to care for, feed, and train their Kryptomon partners in order to grow and prepare for the battles ahead. Kryptomon creates the next step in the evolution of crypto-gaming by using advanced blockchain technologies, digital genetics, and location-based technologies. So what are you waiting for? Play and participate in the Kryptomon league to become the Kryptomon Metaverse Champion!
- OurRitual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback
- Sensi.Ai — Sensi.Ai developed the first audio AI that's able to analyze the routine in long term care environments, detect anomalies and provide insight on trends, with the purpose of improving the quality of care
CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.
Show more
Investment focus
- Software, Analytics, Big Data
- Series B, Series A, Series C
- Israel, United States, India
Portfolio highlights
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
- Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
Yozma earned worldwide recognition as the founder of Israel's VC industry.
Show more
Investment focus
- Health Care, Medical, Software
- Funding Round, Series B, Seed
- Israel, United States, Australia
Portfolio highlights
- Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
- Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
- UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
EdTech
Biotech
Sustainability
Venture Capital
Beauty
Social Media
Medical
Email
Art
Wellness
Music
Mobile
Franchise
Social Network
Local
Internet
Digital Media
Construction
Manufacturing
eSports
B2B
Sports
Enterprise Software
Legal
Android
Platforms
Photography
Mobile Advertising
Biotechnology
Finance
Hospitality
Fitness
Travel
Recruiting
Cannabis
Wine And Spirits
Medical Device
Crowdfunding
Social
Automotive
CleanTech
Real Estate
Transportation
Mobile Apps
InsurTech
Enterprise
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
LGBT
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Retail
Financial Services
Infrastructure
Life Science
Theatre
Film
Renewable Energy
Non Profit
SaaS
Sporting Goods
Restaurants
Software
Social Impact
Celebrity
Agriculture (agtech)
Cryptocurrency
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Sri Lanka
Chile
Bermuda
Belize
Georgia
Greece
Asia
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Morocco
Malta
Armenia
Mali
Malaysia
Vietnam
Italy
Peru
China
Lithuania
Myanmar
Lebanon
Kuwait
Cayman Islands
Japan
Cambodia
Israel
Panama
Mexico
Kazakhstan
Liberia
Jersey
Philippines
Saudi Arabia
Norway
Mauritius
Kenya
Liechtenstein
Nicaragua
Turkey
Serbia
Brazil
Rwanda
El Salvador
Venezuela
Ukraine
Portugal
Sierra Leone
Zimbabwe
Sweden
Taiwan
Oceania
Senegal
Uruguay
Dominican Republic
Uganda
Tunisia
Nigeria
San Marino
Slovenia
Zambia
Uzbekistan
Russian Federation
Seychelles
Azerbaijan
Thailand
Namibia
Iceland
Puerto Rico
Tajikistan
Togo
Poland
Tanzania
United Arab Emirates
Iraq
Honduras
Bahamas
Bolivia
Isle of Man
Luxembourg
Latvia
Albania
Pakistan
Grenada
Jordan
Romania
Argentina
Bangladesh
Cyprus
Oman
Austria
Cameroon
Switzerland
Marshall Islands
Colombia
Guatemala
Investors in Israel by industry
Restaurants
Oil and Gas
Transportation
Education
Crowdfunding
Financial Services
Big Data
Venture Capital
Cryptocurrency
Finance
Payments
Food and Beverage
Organic Food
Video Games
Medical
Fitness
Medical Device
Wellness
Email
Social Media
Internet
Manufacturing
Art
Android
Mobile
Blockchain
Construction
Software
Local
Legal
Digital Media
Enterprise Software
Sports
eSports
Automotive
CleanTech
Hospitality
Travel
Recruiting
InsurTech
Platforms
Cannabis
Biotechnology
Health Care
Enterprise
EdTech
Sustainability
Proptech
Energy
Impact
SaaS
Community
Artificial intelligence
Hardware
Real Estate
Gaming
Retail
Mobile Apps
Social
Infrastructure
Fashion
Beauty
Web3
Photography
Publishing
B2B
Clean Energy
Renewable Energy
Life Science
Biotech
Social Network
FinTech
Music
Marketplace
Agriculture (agtech)
Media (entertainment)
Consumer
Social Impact
Mobile Advertising
Climate